TrialDrug design, development and therapy2015

Cost-effectiveness analysis of lamivudine, telbivudine, and entecavir in treatment of chronic hepatitis B with adefovir dipivoxil resistance.

Guiliang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.